TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Applications Sought for Exploratory/Developmental Projects in Translational Research

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

The National Institute of Neurological Disorders and Stroke (NINDS) invites grant applications for exploratory/developmental projects in translational research.*

Remarkable insights have been made recently into the molecular, genetic, and cellular bases of neurological disease.   In many cases, developmental work must be completed before the basic research results can be translated into effective therapies.   A key requirement for successful therapeutic development is the characterization of new assays, models, tools, and technologies that provide for reliable discovery and testing of therapies.

Areas of research interest include, but are not limited to:  identification of targets for therapeutic intervention; development of assays that permit the preliminary screening of candidate therapeutics; development of animal models that permit further evaluation of candidate therapeutics and/or toxicology studies; development of tools and technologies that can be directly used for therapy development; preliminary identification of candidate therapeutics that can be evaluated through further preclinical testing; and testing of therapeutics for efficacy in cell-based or animal models of a neurological disorder.

For more information, potential applicants should contact Dr. Thomas Miller, Program Director, Technology Development Group, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2139, Bethesda, MD   20892; telephone:  301-496-1779; fax:  301-402-1501; e-mail:

*For a more detailed description of this program announcement, please visit the NIH web site at: